GALVANY DEVELOPMENTS LTD
Company number 10971673 · Active · Stevenage SG1 2DX
GALVANY DEVELOPMENTS LTD is an active private limited company (company number 10971673) incorporated on 19 September 2017, registered in Stevenage. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2025, showing net assets of £172k and cash of £3,958, with 3 employees on average. Net assets fell 19% on the prior period (£212k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
Key dates
- Incorporated
- 19 September 2017
- Next accounts due
- 30 September 2027 — in 344 days
- Confirmation statement due
- 3 October 2027 — in 347 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 3 periods on record, latest ending 31 December 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £172k | £3,958 | £217k | — | — | — | 3 |
| 31 December 2024 | £212k | £50k | £625k | — | — | — | 3 |
| 31 December 2023 | £945k | £303k | £267k | — | — | — | 3 |
- Cash per employee
- £1,319
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 73/100 (grade B)
- +10 Positive net assets — Net assets £172,279 at 2025-12-31
- +5 Multi-year filing history — 3 periods on record
- +8 Established — Incorporated 2017-09-19 (9 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Galvany Pharma Limited (corporate entity, England) — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 25 July 2022
- Synchrony Pharma Ltd (corporate entity, United Kingdom) — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 19 September 2017 · ceased 25 July 2022
- Solar Uk Opco Limited (corporate entity, England) — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 25 July 2022 · ceased 25 July 2022
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Hertfordshire
Same activity (manufacture of basic pharmaceutical products), closest in incorporation date.
- SOLENT ORAL CARE LTD — St Albans, inc. Jun 2017
- LIQUIDSUN LTD — Welwyn Garden City, inc. Jun 2016
- AVACARE LIMITED — Letchworth, inc. Apr 2016
- ACIUM LTD — Stevenage, inc. Mar 2015
- NOBLE HEALTHCARE LIMITED — Sandy, inc. Jan 2021
- PHARMA XP CONSULTING LTD — Hertford, inc. Jan 2014
Reminders for GALVANY DEVELOPMENTS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.